- Filed
- May 3, 2022 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2022 · Apr 26, 2022 | 33.32M sh |
| Shares Diluted | Q1 2022 · Mar 31, 2022 | 33.16K sh |
| Shares Diluted restated | Q1 2022 · Mar 31, 2021 | 32.95K sh |
| Stock Repurchased | Q1 2022 · Mar 31, 2022 | $175K |
| Stock Repurchased | Q1 2022 · Mar 31, 2021 | $310K |
| Capex | Q1 2022 · Mar 31, 2022 | $31.18M |
| Capex | Q1 2022 · Mar 31, 2021 | $7.2M |
| Operating Cash Flow | Q1 2022 · Mar 31, 2022 | −$24.94M |
| Operating Cash Flow | Q1 2022 · Mar 31, 2021 | $3.19M |
| Short Term Debt | Q1 2022 · Mar 31, 2022 | $798K |
| Short Term Debt | Q1 2022 · Dec 31, 2021 | $1.4M |
| Cash And Equivalents | Q1 2022 · Mar 31, 2022 | $60M |
| Cash And Equivalents | Q1 2022 · Dec 31, 2021 | $56.26M |
| Stockholders Equity | Q1 2022 · Mar 31, 2022 | $158.01M |
| Stockholders Equity | Q1 2022 · Dec 31, 2021 | $183.59M |
| Stockholders Equity | Q1 2022 · Mar 31, 2021 | $264.71M |
| Stockholders Equity | Q1 2022 · Dec 31, 2020 | $295.83M |
| Current Liabilities | Q1 2022 · Mar 31, 2022 | $290.64M |
| Current Liabilities | Q1 2022 · Dec 31, 2021 | $290.09M |
| Total Liabilities | Q1 2022 · Mar 31, 2022 | $1.06B |
| Total Liabilities | Q1 2022 · Dec 31, 2021 | $995.61M |
| Current Assets | Q1 2022 · Mar 31, 2022 | $413.86M |
| Current Assets | Q1 2022 · Dec 31, 2021 | $408.4M |
| Total Assets | Q1 2022 · Mar 31, 2022 | $1.22B |
| Total Assets | Q1 2022 · Dec 31, 2021 | $1.18B |
| Sga Expense | Q1 2022 · Mar 31, 2022 | $41.88M |
| Sga Expense | Q1 2022 · Mar 31, 2021 | $32.63M |
| Net Income | Q1 2022 · Mar 31, 2022 | −$29.65M |
| Net Income | Q1 2022 · Mar 31, 2021 | −$29.87M |
| Cost Of Revenue | Q1 2022 · Mar 31, 2022 | $119.46M |
| Cost Of Revenue | Q1 2022 · Mar 31, 2021 | $68.93M |
| Revenue | Q1 2022 · Mar 31, 2022 | $191.75M |
| Revenue | Q1 2022 · Mar 31, 2021 | $136.16M |